相关实验视频
Updated: Jul 13, 2026

05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
269
胆囊癌的新辅助疗法改善了切除能力和生存率:一项前性研究
Anupam Lahiri1, Suchita Chowdhury2, Shaifali Goel1
1Department of GI and HPB Services, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, New Delhi, 110085, India.
概括
新辅助化疗 (NACT) 显著改善了胆囊癌的切除率,在完成治疗的60%以上的患者中提供了治疗性手术的机会. 这种方法显示出对本地晚期疾病的生存益处有希望.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 化疗 化疗是一种化学疗法.
背景情况:
- 胆囊癌在诊断时具有有限的切除能力,预后不佳.
- 对胆囊癌的新辅助化疗 (NACT) 的疗效尚未得到充分证实.
研究的目的:
- 评估NACT对胆囊癌患者切除能力和生存结果的影响.
- 评估NACT在未来临床环境中的安全性和可行性.
主要方法:
- 一项前性单中心研究,涉及226名胆囊癌患者.
- 患者接受了基于格姆西塔和的NACT,随后进行了反应评估.
- 主要终点包括实现切除能力和整体存活率.
主要成果:
- 治疗意图切除率为36.2%,在完成NACT.的人群中增加到60.7%.
- 在95.1%的切除患者中实现了R0切除.
- 可切除病例的平均整体存活时间为27个月,而不可切除病例的平均存活时间为13个月 (p < 0.001).
- 在9.7%的患者中发生了≥3级毒性,与治疗相关的死亡率为1.7%.
结论:
- 在完成治疗的胆囊癌患者中,NACT显著提高了治愈切除率.
- 这些发现支持将NACT纳入局部晚期胆囊癌的治疗策略.
- NACT证明了可接受的毒性概况和改善的生存结果.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: